awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36161541-8D4D8A30-C0E2-464E-A152-39859E5CE70B
Q36161541-8D4D8A30-C0E2-464E-A152-39859E5CE70B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36161541-8D4D8A30-C0E2-464E-A152-39859E5CE70B
Adding to the mix: fibroblast growth factor and platelet-derived growth factor receptor pathways as targets in non-small cell lung cancer
P2860
Q36161541-8D4D8A30-C0E2-464E-A152-39859E5CE70B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36161541-8D4D8A30-C0E2-464E-A152-39859E5CE70B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4b32e148014b4694ca17b1db263c0c04e4fae0f2
P2860
A phase I and pharmacokinetic study of daily oral cediranib, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer: a study of the Nati